ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Incyte Genomics, Inc.
(NQ:
INCY
)
23.04
USD
-0.13 (-0.56%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
23.26
Bid (Size)
23.04 (9700)
Ask (Size)
23.05 (400)
Prev. Close
23.17
Today's Range
22.74 - 23.43
52wk Range
15.43 - 26.30
Shares Outstanding
135,749,206
Dividend Yield
N/A
Featured News
More News
Gilead Makes Another Bet on Cancer, Incyte Shares Fall
December 12, 2012
MINYANVILLE ORIGINAL In the biotech world a half-billion-dollar deal is still a lot of money. For Gilead Sciences (NASDAQ:GILD) a $58 billion market-cap company the takeover of YM BioSciences...
Read More
from
Minyanville Headlines
Eli Lilly and Other Healthcare Stocks Making Big Moves on December 12, 2012
December 12, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has moved up 0.2% and the Dow is up 0.2% after the morning's trading. The healthcare sector is the category of stocks relating to medical and healt...
Read More
from
Investopedia Advisor Commentary
Featured News
Read More
Can Pfizer's New Drug Clip Abbott's Top-Selling Humira?
November 07, 2012
from
Minyanville Headlines
Edwards Lifesciences Among Healthcare's Biggest Movers on September 24, 2012
September 24, 2012
from
Investopedia Advisor Commentary
Med-Tech Matterhorn?
September 06, 2012
category
HPQ
,
Opinion
,
Commentary
, and 6 more.
from
MarketWatch
Big Movers on the Healthcare Sector Today, Including BMY
August 02, 2012
from
Investopedia Advisor Commentary
Incyte Corporation and Other Nasdaq Stocks Making Big Moves
August 02, 2012
from
Investopedia Advisor Commentary
Buyouts boost volatile medical tech sector
July 23, 2012
category
AMLN
,
Opinion
,
INCY
, and 2 more.
from
MarketWatch
More News
Read More
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCY
May 10, 2013
from
GlobeNewswire News Releases
Six Superstars for Your Biotech Portfolio: John McCamant
May 09, 2013
category
AZN
,
JNJ
,
ALKS
, and 8 more.
from
Bio-Wire.Com
Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-time Highs
May 07, 2013
category
anr
,
anf
,
ea
, and 22 more.
from
DailyFinance.com
Goldman Sachs Resumes Incyte (INCY) at Sell, Competition to Roil Jakafi Launch
May 07, 2013
from
StreetInsider.com News Articles
Incyte to Present at Upcoming Investor Conferences
May 03, 2013
from
Business Wire News Releases
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline
May 02, 2013
from
Business Wire News Releases
Incyte (INCY) Posts Q1 Loss of 12c/Share
May 02, 2013
from
StreetInsider.com News Articles
Incyte Reports First-Quarter 2013 Financial Results; Updates Shareholders on Key Clinical Programs
May 02, 2013
from
Business Wire News Releases
Trading Radar for 05/02: MGM Resorts (MGM), GM (GM), Kraft Foods (KRFT), athenahealth (ATHN) Report
May 01, 2013
from
StreetInsider.com News Articles
Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development
April 29, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
2
The Top 5 Spookiest Technologies
Nick Shchetko
3
The Tesla Model S Is the New Toyota Prius
Michael Comeau
4
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
5
BlackBerry: Why Expanding BBM to iOS and Android Is Smart -- and Hazardous
Sterling Wong
See All Articles
»
Financial Product Guide